Yanyan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yanyan Li has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Maofu Liao
Department of Chemical Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China
5 shared publications - Jin Zhang
School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330031, People's Republic of China
3 shared publications Li Wan
Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China
3 shared publicationsWeiwei Nan
The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China
3 shared publicationsYuanyuan Zhang
Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang 310024, China; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang 310024, China; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang 310024, China; School of Food Science and Biotechnology Engineering, Zhejiang Gongshang University, Hangzhou, Zhejiang 310018, China
3 shared publicationsChen Xu
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, USA
2 shared publications
Latest Publications
- 19 October 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 321 (Pt 2) , 119429
Structure-activity relationship (SAR) studies of abaucin derivatives targeting the lipoprotein transport system in Acinetobacter baumannii
- 19 October 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 321 (Pt 2) , 119429
Structure-activity relationship (SAR) studies of abaucin derivatives targeting the lipoprotein transport system in Acinetobacter baumannii
- Open Access
- 15 September 2026
- Published by Springer Nature in npj Antimicrobials and Resistance
Non‑nucleoside inhibitors of SARS‑CoV‑2 RdRp identified by high‑throughput screening and an approach to their mechanism of action by comparative studies
The RNA-dependent RNA polymerase (RdRp) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pivotal antiviral target due to its essential role in viral replication and high conservation. Non-nucleoside analog inhibitors (NNIs) are a promising class of antiviral compounds that target SARS-CoV-2 RdRp, potentially circumventing resistance profiles associated with nucleoside analogues. Although multiple NNIs against SARS-CoV-2 RdRp have been reported, the knowledge regarding the modes of action remains fragmented, and the lack of a standardized cell-free assay has hindered cross-comparison of various NNIs. Notably, whether clinically approved drugs or the NNIs targeting hepatitis C virus (HCV) RdRp (NS5B) can be used to inhibit SARS-CoV-2 RdRp remains largely unexplored, and the chemical and mechanistic diversity of the NNIs are poorly defined. Here, we conducted a high-throughput screening of an FDA-approved drug library using a fluorescence-based RNA polymerase assay to identify novel NNIs targeting SARS-CoV-2 RdRp. Twenty-nine primary hits, along with sixteen previously reported SARS-CoV-2 NNIs and ten HCV RdRp NNIs, were systematically evaluated using a gel-based RdRp inhibition assay, resulting in seventeen positive compounds which include five novel inhibitors (verteporfin, benzbromarone, epigallocatechin gallate, mitoxantrone, and trifarotene) and two NNIs targeting HCV NS5B (JTK-109 and BILB-1941). Parallel dose-response analysis enabled direct efficacy comparison of the NNIs, showing suramin, C646, and baicalein as the most potent inhibitors. Gel mobility shift assay further revealed varied kinetics of the NNIs in disrupting the RdRp-RNA interaction, reflecting their diverse inhibitory mechanisms. Together, our findings expand the repertoire of NNIs against SARS-CoV-2 RdRp, establish a unified framework for comparative evaluation of RdRp inhibitors, and provide insights into the differential impacts of the NNIs on RdRp-RNA complex formation, thereby supporting future development of allosteric antiviral therapeutics.
- 15 September 2026
- Published by Springer Nature in npj Antimicrobials and Resistance
Open AccessNon‑nucleoside inhibitors of SARS‑CoV‑2 RdRp identified by high‑throughput screening and an approach to their mechanism of action by comparative studies
The RNA-dependent RNA polymerase (RdRp) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pivotal antiviral target due to its essential role in viral replication and high conservation. Non-nucleoside analog inhibitors (NNIs) are a promising class of antiviral compounds that target SARS-CoV-2 RdRp, potentially circumventing resistance profiles associated with nucleoside analogues. Although multiple NNIs against SARS-CoV-2 RdRp have been reported, the knowledge regarding the modes of action remains fragmented, and the lack of a standardized cell-free assay has hindered cross-comparison of various NNIs. Notably, whether clinically approved drugs or the NNIs targeting hepatitis C virus (HCV) RdRp (NS5B) can be used to inhibit SARS-CoV-2 RdRp remains largely unexplored, and the chemical and mechanistic diversity of the NNIs are poorly defined. Here, we conducted a high-throughput screening of an FDA-approved drug library using a fluorescence-based RNA polymerase assay to identify novel NNIs targeting SARS-CoV-2 RdRp. Twenty-nine primary hits, along with sixteen previously reported SARS-CoV-2 NNIs and ten HCV RdRp NNIs, were systematically evaluated using a gel-based RdRp inhibition assay, resulting in seventeen positive compounds which include five novel inhibitors (verteporfin, benzbromarone, epigallocatechin gallate, mitoxantrone, and trifarotene) and two NNIs targeting HCV NS5B (JTK-109 and BILB-1941). Parallel dose-response analysis enabled direct efficacy comparison of the NNIs, showing suramin, C646, and baicalein as the most potent inhibitors. Gel mobility shift assay further revealed varied kinetics of the NNIs in disrupting the RdRp-RNA interaction, reflecting their diverse inhibitory mechanisms. Together, our findings expand the repertoire of NNIs against SARS-CoV-2 RdRp, establish a unified framework for comparative evaluation of RdRp inhibitors, and provide insights into the differential impacts of the NNIs on RdRp-RNA complex formation, thereby supporting future development of allosteric antiviral therapeutics.
- 25 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6805) , eadz8141
Cryo–electron microscopy structures of human cone visual pigments
Human trichromatic color vision relies on three cone opsins [long-, middle-, and short-wavelength-sensitive opsins (LWS-, MWS-, and SWS-opsins, respectively)], whereas scotopic rod vision is mediated by rhodopsin. Although the structure of rhodopsin was solved more than 20 years ago, cone opsin structures have been lacking. Here, we present cryo–electron microscopy structures of the three human cone opsins, each bound to a G protein and all- trans retinal in the presumed active state. All three cone opsins differ markedly from rhodopsin. Within the retinal binding pocket, we identified a distinct counterion site (LWS- and MWS-opsins) and a ring of serines around the retinal (SWS-opsin). The active cone opsin structures explain how amino acid substitutions fine-tune spectral sensitivity and help clarify the molecular basis of color vision deficiencies and key differences in rod versus cone activation.
- 25 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6805) , eadz8141
Cryo–electron microscopy structures of human cone visual pigments
Human trichromatic color vision relies on three cone opsins [long-, middle-, and short-wavelength-sensitive opsins (LWS-, MWS-, and SWS-opsins, respectively)], whereas scotopic rod vision is mediated by rhodopsin. Although the structure of rhodopsin was solved more than 20 years ago, cone opsin structures have been lacking. Here, we present cryo–electron microscopy structures of the three human cone opsins, each bound to a G protein and all- trans retinal in the presumed active state. All three cone opsins differ markedly from rhodopsin. Within the retinal binding pocket, we identified a distinct counterion site (LWS- and MWS-opsins) and a ring of serines around the retinal (SWS-opsin). The active cone opsin structures explain how amino acid substitutions fine-tune spectral sensitivity and help clarify the molecular basis of color vision deficiencies and key differences in rod versus cone activation.
- Open Access
- 6 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Structure and druggable conformation of the homodimeric lipoprotein transporter of Acinetobacter baumannii
The growing crisis of antimicrobial resistance demands urgent need for antibiotics with alternative targets and modes of action (MOAs). Lipoproteins play crucial roles in bacterial survival and immunoregulation. The lipoprotein transporter, known as LolCDE or LolDF, has recently emerged as an effective target for selectively killing pathogenic bacteria such as Acinetobacter baumannii while sparing gut microbiota. While the heterodimeric LolCDE in Escherichia coli has been extensively studied, the druggable pocket and structural dynamics of the distinct homodimeric LolDF that exists in many critical pathogens are poorly understood. Such a knowledge gap limits our ability to exploit the Lol system to develop drugs with desired spectra of antibacterial activity. Here we determine the cryo-EM structures of homodimeric LolDF of A. baumannii in nucleotide-free apo-closed, vanadate-trapped fully closed, and inhibitor-bound open conformations, revealing the distinct structural features and conformational cycle of LolDF. Further cryo-EM, biochemical and functional analyses uncover the MOA of abaucin, a recently identified LolDF-targeting compound, demonstrating how multiple abaucin molecules open LolDF in a stepwise manner to establish an induced-fit pocket. Together, our results advance the understanding of LolDF function and inhibition, and provide the cryptic druggable conformation and specific inhibitor-bound pocket for structure-based drug discovery to target the dynamic lipoprotein transporter in A. baumannii.
- 6 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessStructure and druggable conformation of the homodimeric lipoprotein transporter of Acinetobacter baumannii
The growing crisis of antimicrobial resistance demands urgent need for antibiotics with alternative targets and modes of action (MOAs). Lipoproteins play crucial roles in bacterial survival and immunoregulation. The lipoprotein transporter, known as LolCDE or LolDF, has recently emerged as an effective target for selectively killing pathogenic bacteria such as Acinetobacter baumannii while sparing gut microbiota. While the heterodimeric LolCDE in Escherichia coli has been extensively studied, the druggable pocket and structural dynamics of the distinct homodimeric LolDF that exists in many critical pathogens are poorly understood. Such a knowledge gap limits our ability to exploit the Lol system to develop drugs with desired spectra of antibacterial activity. Here we determine the cryo-EM structures of homodimeric LolDF of A. baumannii in nucleotide-free apo-closed, vanadate-trapped fully closed, and inhibitor-bound open conformations, revealing the distinct structural features and conformational cycle of LolDF. Further cryo-EM, biochemical and functional analyses uncover the MOA of abaucin, a recently identified LolDF-targeting compound, demonstrating how multiple abaucin molecules open LolDF in a stepwise manner to establish an induced-fit pocket. Together, our results advance the understanding of LolDF function and inhibition, and provide the cryptic druggable conformation and specific inhibitor-bound pocket for structure-based drug discovery to target the dynamic lipoprotein transporter in A. baumannii.
- 15 August 2024
- Published by Elsevier in Journal of Structural Biology
- Vol. 216 (3) , 108117
Structural analysis of the human C5a-C5aR1 complex using cryo-electron microscopy
- 15 August 2024
- Published by Elsevier in Journal of Structural Biology
- Vol. 216 (3) , 108117
Structural analysis of the human C5a-C5aR1 complex using cryo-electron microscopy
- Open Access
- 16 April 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (6) , 107288
Cryo-EM structure of human HCN3 channel and its regulation by cAMP
- 16 April 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (6) , 107288
Open AccessCryo-EM structure of human HCN3 channel and its regulation by cAMP
- Open Access
- 12 April 2023
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 117, 109340
Corrigendum to “A steamed broccoli sprout diet preparation that reduces colitis via the gut microbiota” [J Nutr Biochem 2023;112:109215]
- 12 April 2023
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 117, 109340
Open AccessCorrigendum to “A steamed broccoli sprout diet preparation that reduces colitis via the gut microbiota” [J Nutr Biochem 2023;112:109215]
- 21 February 2023
- Published by Oxford University Press (OUP) in Journal of Experimental Botany
- Vol. 74 (10) , 3060-3073
FRUCTOSE INSENSITIVE1 regulates stem cell function in Arabidopsis in response to fructose signalling
Stem cell function in different meristems of Arabidopsis is mainly defined by WUSCHEL (WUS)/WUSCHEL-RELATED HOMEOBOX (WOX) family proteins. Sugars also have been demonstrated to play pivotal roles in stem cell function and development of plant. As a cytosolic fructose-1.6-bisphosphatase, FRUCTOSE INSENSITIVE1 (FINS1) has been demonstrated to regulate plant growth in response to fructose signaling. So far, it remains to be elucidated how stem cell function is regulated in response to fructose signaling. Our work showed that FINS1 interacts with WUS/WOX protein as a complex, which further binds to WUS/WOX promoter and regulates WUS/WOX expression in response to fructose signaling. FINS1 might act as a bifunctional factor that promotes WUS/WOX expression in the presence of low levels of fructose and represses WUS/WOX expression in the presence of high levels of fructose. Therefore, FINS1 regulates stem cell function in response to fructose signaling during the growth and development of Arabidopsis.
- 21 February 2023
- Published by Oxford University Press (OUP) in Journal of Experimental Botany
- Vol. 74 (10) , 3060-3073
FRUCTOSE INSENSITIVE1 regulates stem cell function in Arabidopsis in response to fructose signalling
Stem cell function in different meristems of Arabidopsis is mainly defined by WUSCHEL (WUS)/WUSCHEL-RELATED HOMEOBOX (WOX) family proteins. Sugars also have been demonstrated to play pivotal roles in stem cell function and development of plant. As a cytosolic fructose-1.6-bisphosphatase, FRUCTOSE INSENSITIVE1 (FINS1) has been demonstrated to regulate plant growth in response to fructose signaling. So far, it remains to be elucidated how stem cell function is regulated in response to fructose signaling. Our work showed that FINS1 interacts with WUS/WOX protein as a complex, which further binds to WUS/WOX promoter and regulates WUS/WOX expression in response to fructose signaling. FINS1 might act as a bifunctional factor that promotes WUS/WOX expression in the presence of low levels of fructose and represses WUS/WOX expression in the presence of high levels of fructose. Therefore, FINS1 regulates stem cell function in response to fructose signaling during the growth and development of Arabidopsis.
- Open Access
- 3 August 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-11
Mechanism of LolCDE as a molecular extruder of bacterial triacylated lipoproteins
Lipoproteins are important for bacterial growth and antibiotic resistance. These proteins use lipid acyl chains attached to the N-terminal cysteine residue to anchor on the outer surface of cytoplasmic membrane. In Gram-negative bacteria, many lipoproteins are transported to the outer membrane (OM), a process dependent on the ATP-binding cassette (ABC) transporter LolCDE which extracts the OM-targeted lipoproteins from the cytoplasmic membrane. Lipid-anchored proteins pose a unique challenge for transport machinery as they have both hydrophobic lipid moieties and soluble protein component, and the underlying mechanism is poorly understood. Here we determined the cryo-EM structures of nanodisc-embedded LolCDE in the nucleotide-free and nucleotide-bound states at 3.8-Å and 3.5-Å resolution, respectively. The structural analyses, together with biochemical and mutagenesis studies, uncover how LolCDE recognizes its substrate by interacting with the lipid and N-terminal peptide moieties of the lipoprotein, and identify the amide-linked acyl chain as the key element for LolCDE interaction. Upon nucleotide binding, the transmembrane helices and the periplasmic domains of LolCDE undergo large-scale, asymmetric movements, resulting in extrusion of the captured lipoprotein. Comparison of LolCDE and MacB reveals the conserved mechanism of type VII ABC transporters and emphasizes the unique properties of LolCDE as a molecule extruder of triacylated lipoproteins.
- 3 August 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-11
Open AccessMechanism of LolCDE as a molecular extruder of bacterial triacylated lipoproteins
Lipoproteins are important for bacterial growth and antibiotic resistance. These proteins use lipid acyl chains attached to the N-terminal cysteine residue to anchor on the outer surface of cytoplasmic membrane. In Gram-negative bacteria, many lipoproteins are transported to the outer membrane (OM), a process dependent on the ATP-binding cassette (ABC) transporter LolCDE which extracts the OM-targeted lipoproteins from the cytoplasmic membrane. Lipid-anchored proteins pose a unique challenge for transport machinery as they have both hydrophobic lipid moieties and soluble protein component, and the underlying mechanism is poorly understood. Here we determined the cryo-EM structures of nanodisc-embedded LolCDE in the nucleotide-free and nucleotide-bound states at 3.8-Å and 3.5-Å resolution, respectively. The structural analyses, together with biochemical and mutagenesis studies, uncover how LolCDE recognizes its substrate by interacting with the lipid and N-terminal peptide moieties of the lipoprotein, and identify the amide-linked acyl chain as the key element for LolCDE interaction. Upon nucleotide binding, the transmembrane helices and the periplasmic domains of LolCDE undergo large-scale, asymmetric movements, resulting in extrusion of the captured lipoprotein. Comparison of LolCDE and MacB reveals the conserved mechanism of type VII ABC transporters and emphasizes the unique properties of LolCDE as a molecule extruder of triacylated lipoproteins.